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Abstract
The purpose of this mixed methods research study was to examine the role of adherence
barriers to healthcare and the impact that such barriers have on highly active
antiretroviral therapy (HAART) compliance for African Americans living with
HIV/AIDS. HAART helps reduce HIV/AIDS morbidity and mortality. Of the 49% of
study participants who had been out of medical care for more than 12 months, financial
concerns were listed as the most common barrier (22.8%). Not having the support from
family and friends (17.5%), being tired of going to doctor appointments (15.8%), health
challenges (12.3%), lack of transportation (12.3%), and incarceration (12.3%) were also
barriers in medical care that had a direct influence on noncompliance. The overall model
of the linear regression analysis was significant, R2 = .469, adjusted R2 = .458, F(1, 49) =
43.24, p < .001. Being in medical care on a regular basis accounted for 46.9% of the total
variance in attending primary care visits. The outcome of this analysis confirms the
hypotheses (HA1) that attending 2 primary care visits within 6 months of being linked to
care increased the rate of compliance for African Americans on HAART living with
HIV/AIDS. The overall model of the linear regression analysis was significant, R2 = .469,
adjusted R2 = .458, F(1, 49) = 7.206, p < .001. Being in medical care on a regular basis
accounted for 46.9% of the total variance in attending primary care visits. The outcome
of this analysis empasizes the importance of HAART compliance. These findings can
lead to positive social changes by improving quality of life and health, which impacts
gainful employment, sustains positive relationships, improves finances, and increases
self-sufficiency.
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Chapter 1: Introduction to the Study
Introduction
Piot, Kazatchkine, Dybul, and Lob-Levyt (2009) noted that the emergence of the
human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
began around the 1980s. The global effect that the virus and its related disease was
underestimated. Tens of millions of individuals in the world would become infected
within a few decades (Piot et al., 2009). The disease continues to leave communities
devastated on a global level. Unfortunately, not all persons who are diagnosed as being
infected with HIV (also referred to as being HIV positive) or develop AIDS have access
to the necessary healthcare and medication. As such, HIV/AIDS is now a global health
issue, major public health concern, and human rights issue.
Identified as a global pandemic, more than 34 million people now live with
HIV/AIDS worldwide (World Health Organization [WHO], 2013). HIV is spread through
the exchange of bodily fluids (blood, vaginal fluids, semen, preseminal fluid, rectal
fluids, and breast milk) from a person infected with HIV through high risk behaviors such
as oral, vaginal, anal sex, and sharing needles or syringes (Centers for Disease Control
and Prevention [CDC], 2014). Mother to child transmission of the virus is another form
of transmission that can occur during pregnancy; however, if a pregnant woman does not
breastfeed, has an undetectable viral load, and is on prescribed medication, the risk of
transmission is reduced to 1% (CDC, 2014). While numerous scientific accomplishments
resulted in treating this disease and determining its etiology, there is no cure, and millions
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of people continue to become infected with HIV or die from complications associated
with AIDS annually (Schneiderman, 2001).
Clinical trials have been unsuccessful in the development of a vaccination to
prevent the occurrence of HIV/AIDS (Virgin & Walker, 2010). Therefore, methods of
prevention include safe sex practices and health education. Unfortunately, safer sex
methods are not always practiced (Nkansah-Amankra et al., 2011). This increases risk as
persons who become infected with herpes, gonorrhea, or syphilis also increase their
chances of becoming infected with HIV (CDC, 2015c). Additionally, education, at times,
may not suffice to induce healthy behavior modification practices as it relates to the
prevention of diseases (Nkansah-Amankra, et al., 2011). Fortunately, in terms of
treatment options, one advance, highly active antiretroviral therapy (HAART), has
resulted in the reduction of HIV/AIDS transmission, morbidity, and mortality (Montaner
et al., 2014). Recent studies showed an estimated 8 million people living with HIV/AIDS
are receiving HAART, with an estimated 7 million eligible people waiting to enroll in
treatment for HAART (Granich, 2010). As such, ensuring that comprehensive care
happens as soon as possible should be a priority for persons living with HIV/AIDS,
because HAART has shown success in reducing incurred costs and improving clinical
outcomes (Pollini, Blanco, Crump, & Zuniga, 2011).
Interestingly, despite the availability and success of HAART, Kalichman et al.
(2011) noted that individuals who engage in high risk behaviors for HIV infection are
less likely to be adherent to HAART, which is a critical factor in the quality of life. Issues
such as co-morbidities, increase in viral load and decrease of CD4 count are some of the
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reasons that a person living with HIV/AIDS may decide to start HAART. Nutritional
requirements, transportation, finances, stigma, and demographic location can also present
as barriers to appropriate medical care. If an individual lacks food, shelter, or other
medical or behavioral health care, adherence may not be a priority to them. This is of
particular concern in African American communities as health disparities are often
prevalent in this community, especially in the case of HIV/AIDS, and these barriers may
be affecting their decisions regarding health care (Colasanti, Nguyen, Kiem, Deeb, &
Jayaweera, 2012).
Reducing behaviors that could increase fatalities, health issues, and the spread of
disease are important. The potential findings of this research project would lead to
positive social changes by allowing African Americans living with HIV/AIDS to have
life longevity leading to positive behavior changes. This would present opportunities for
gainful employment, sustaining positive relationships, and improving financial stability.
Background
Primary, secondary, and tertiary intervention strategies have been implemented
globally to reduce the spread of HIV/AIDS. For behavioral interventions to succeed in
reducing infections across a population, they need to reach a broader sector of the
population, be of sufficient intensity and reach the proper individuals (Cohen et al.,
2007). Major milestones have been made over the past decade in behavioral research on
how to help persons avoid contracting HIV (primary prevention) and how to reduce or
alleviate adverse consequences among persons who are living with HIV disease
(secondary prevention).
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Within the primary prevention areas, research has shown the effectiveness of riskreduction interventions undertaken with individuals, couples, small groups, communities,
and at a social policy/structural level. Advances in HIV medical care have also created
important new challenges and roles for behavioral scientists in the area of HIV secondary
prevention (Kelly & Kalichman, 2002). Tertiary prevention, in this case, would be more
like slowing or stopping the progression of the diseases, and would rely on treatment with
medication and practicing healthy behaviors.
Montaner et al. (2014) noted that HAART has influenced a profound populationlevel decrease in HIV transmission, mortality and morbidity rates, but adherence to
HAART has been a critical concern for the past decade (Konkle-Parker, Erlen, &
Dubbert, 2007). To date, not much is known about adherence barriers and facilitators
such as being able to accept an HIV/AIDS diagnosis, spirituality and prayer, support
systems from loved ones and the implications of poor medication adherence (KonkleParker et al., 2007). In order to make a positive social change there should be an
understanding of what treatment barriers are and why they exist.
Problem Statement
HAART has been successful in prolonging life expectancy and decreasing the
viral load of HIV in the human body (Cahill & Valadez, 2013). Population Reference
Bureau (2013) highlights that, of all racial or ethnic groups, more African Americans are
living with HIV or already dead from AIDS in the United States than any other ethnic
group. While there has been a decrease in HIV/AIDS cases; the number of African
Americans diagnosed with HIV/AIDS has not (Kaiser Family Foundation, 2014).
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Furthermore, when compared to other minorities, African Americans were more
underserved by the AIDS Drug Assistance Program (ADAP) (Horneffer & Yang, 2013)
and were 2.40 times more likely to be noncompliant with HAART than whites (Osborn,
Paasche-Orlow, Davis, & Wolf, 2007). This study focused on the present gap in
literature, which are the adherence barriers to healthcare for African Americans with
HIV/AIDS on antiretroviral medications.
Purpose of the Study
Capable of generating a major social change, this study was a mixed methods
paradigm. The potential findings of this research project will lead to positive social
changes by allowing African Americans living with HIV/AIDS to have an advanced
quality of life and lead to positive change by being able to improve their health. This
presents opportunities for these individuals to gain employment, sustain positive
relationships, to improve financial stability, present for follow up medical visits and to
even volunteer with local public health agencies that are centered on HIV/AIDS patients
as consumers. Individually and collectively these indicators impact social change in a
progressive manner.
Research Questions and Hypotheses
Qualitative Research Questions
RQ 1. What are the barriers causing African Americans living who with
HIV/AIDS to have lower adherence rates with HAART than persons of other ethnic
groups?
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RQ 2. How can barriers for medical treatment of African Americans living with
HIV/AIDS be eliminated?
Quantitative Research Questions
RQ 3. Will attending two primary care visits within six months of being linked to
care increase the rate of compliance for African Americans on HAART living with
HIV/AIDS?
H01: Attending two primary care visits within six months of being linked to care
will not increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
HA1: Attending two primary care visits within six months of being linked to care
will increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
RQ 4. Will African Americans living with HIV/AIDS who have been out of care
for 12 or more months have a low linkage to care rate?
H02: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will not have a low linkage to care rate.
HA2: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will have a low linkage to care rate.
Framework
The Health Belief Model (HBM) theoretical framework was applicable to this
study because an individual’s perceptions and/or beliefs had a direct impact on strategies
that can decrease disease occurrence (Glanz, Rimer, & Lewis, 2002). These perceptions
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included seriousness, benefits, barriers, and susceptibility (Glanz et al., 2002). The
aforementioned perceptions have a positive or negative influence on a person’s health. As
previously mentioned, individuals who are living with HIV/AIDS, who are on HAART
looked at this part of their medical care as beneficial, but they also viewed it as harmful,
due to some of the possible side effects. Therefore, negative perceptions reduced
compliance with HAART.
Nature of Study
A mixed methods approach, primarily qualitative, was used to address the
questions that were proposed in this study that helped prevent bias. The qualitative
information helped to bridge the gap of knowledge or data collected from the quantitative
data collection tools. The qualitative data consisted of results that identified barriers of
care for study participants. Quantitative data consisted of statistics that showed a direct
correlation of HAART noncompliance and HAART availability. Addressing linkage care
rates resulted in options that are more successful in order for medical and HAART
compliance to occur. Data from the surveys represented an accurate account of barriers
and positive behaviors that affected HAART compliance rates.
Definitions
There are certain acronyms/terms/definitions used in the field of HIV/AIDS that
may not be known to others who are not familiar with these infections or specialty.
Treatment failure. This term is interchangeable with the phrase “drug
resistance”, and is used when a bacterial component, viral agent, or microorganism

8
becoming insensitive to a drug that was previously effective, but is no longer effective
(insensitive) (AIDS Info, 2011).
Highly Active Antiretroviral Therapy (HAART). This is a form of prescription
therapy used to prevent HIV replication and advancement (AIDS Info, 2005).
MSM. This is the acronym for men who have sex with men (Young & Meyer,
2005).
MSMW. This is the acronym for men who have sex with men and women
(Young & Meyer, 2005).
Seroconversion. Transition from HIV infection to being able to detect HIV
antibodies in the blood (AIDS Info, 2005).
WSW. This is the acronym for women who have sex with women (Young &
Meyer, 2005).
WSWM. This is the acronym for women who have sex with men and women
(Young & Meyer, 2005).
Young and Meyer (2005) noted these terms are politically correct terms used in
public health dialogue because not all MSM, WSW, MSMW, and WSWM identify as
being gay, homosexual, bisexual or lesbians. Instead of using these terms as labels, the
acronyms are used as a way of focusing on behaviors instead.
Socioeconomic status (SES). At times, this term is used interchangeably with
“social position.” Socioeconomic status, as noted by the National Center for Health
Statistics (2012), is a “multidimensional concept comprising measures of resources such
as income, wealth, and educational credentials, and the access to goods, services, and
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knowledge that these resources afford those who have them. It is most commonly
measured using educational attainment, income or poverty status, and, when available,
wealth, employment, and occupational status” (p. 24).
Social position. This term is similar to and is often interchanged with SES, but it
encompasses a look at the level of education achieved, financial stability and income, and
occupational level (Strenze, 2007). An individual’s social position at any given time is
identified as attained social position (Strenze, 2007).
Human Immunodeficiency Virus (HIV). This term is used interchangeably for
the HIV virus and the infection it causes. According to AIDS Info (2013), the HIV virus
composed of the following five components:
HIV Envelope. This is the outer surface of HIV.
HIV RNA. This is the genetic material of HIV.
HIV Capsid. This is a bullet-shaped core that contains the RNA of HIV.
HIV Enzymes. These are proteins that carry out the steps in the life cycle of HIV.
HIV Glycoproteins. These are protein “spikes” that are embedded in the envelope
of HIV.
Protease. This enzyme is defined by AIDS info (2013) as a protein that breaks up
the long protein chains that form the underdeveloped HIV.
CD4 cells. Also, known as helper T cells or CD4 lymphocytes, these are white
blood cells that work to fight infections in the body (AIDS Info, 2005). A persons CD4
cell count has a direct impact on their immune system (AIDS Info, 2005). A
normal/healthy CD4 count ranges from 500 to 1,400 cells (AIDS Info, 2005). Whenever
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a person infected with HIV has a CD4 cell count at or below 200, they are diagnosed as
having AIDS (AIDS Info, 2005).
Viral load. The amount of HIV in a sample of blood is known as a viral load
(AIDS Info, 2005). The viral load is the quantity of HIV copies per ml of blood (AIDS
Info, 2005). As CD4 counts have a range, viral loads have a range as well. Viral load
counts range from undetectable or as high as 750,000 (AIDS Info, 2005). Viral loads are
used to determine the best options for HAART (AIDS Info, 2005).
Post-exposure prophylaxis (PEP). This term describes a medication treatment
involving antiretroviral medications no later than 3 days of a possible exposure to HIV
(CDC, 2015a). This helps to reduce the possibility of becoming infected with HIV. PEP
can also be used after sexual assaults and for healthcare workers that have been exposed
to HIV through infected fluids or needle sticks (CDC, 2015a).
Pre-exposure prophylaxis (PrEP). This term describes a medication treatment
that involves taking antiretroviral medications on a daily basis to prevent HIV infection
(CDC, 2015a).
HIV progression/clinical progression. Both terms refer to measurements that are
observable and diagnosable relating to signs and symptoms, such as CD4 counts and viral
loads (AIDS Info, 2011).
Treatment Regimen. This term is interchangeably used with recommended
regimen and treatment therapy to describe a structured a treatment plan focused on
improving or maintain health and often requires prescription therapy with a combination
of HAART from at least two drug classes as a component (AIDS Info, 2011).
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Person-years. This is a measurement combining the number of persons and their
time contribution in a research study. It is the sum of individual units of time that the
persons in the study population have been exposed or at risk to the conditions of interest.
It is not the same as persons per year.
The Life Cycle of HIV+
To understand the HIV life cycle, it helps to first understand what HIV looks like.
As noted and illustrated in Figure 1, there are five components that make up the HIV cell.

Figure 1. The components of the HIV virus. This figure is an illustration of the major
component of the HIV virus and their functions (AIDS Info, 2013).
In order for HIV to spread it must attack and infect CD4 cells as a means of
completing its life cycle. AIDS info (2015) and The Body (2013) noted several stages in
the life cycle of HIV (Figure 2).
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Figure 2. The Life Cycle of HIV. This is an illustration of the seven phases of the life
cycle of HIV, a description of what happens during each phase, and the types of
medications that block each phase (The Body, 2013).
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Assumptions, Scope, Delimitations and Limitations
Assumptions
An assumption that all study participants will honestly answer and complete all of
the survey questions is valid since the survey will be administered anonymously.
Although they survey is anonymous, some clients may prefer to answer survey questions
in a private setting allowing them the ease and will to answer questions in a more honest
manner.
Scope and Delimitations
This study was geared towards male, female, and transgendered African
Americans living with HIV/AIDS who were or are presently taking HAART. They are
receiving some form of medical care for their HIV/AIDS infection, even if it is not
HAART. This study took place in Atlanta, Georgia.
Limitations
Capturing honest and accurate information was a limitation. As previously stated,
a mixed methods approach, primarily qualitative, was used for the nature of the research
study. Due to the content of the research questions and information that were collected,
this approach was most sufficient. This helped to prevent bias.
Qualitative information helped to bridge the gap of knowledge or data collected
from the Quantitative data collection tools. Quantitative data consisted of statistics that
showed a direct correlation of HAART noncompliance and HAART availability. Data
from the survey represented an accurate account of barriers and positive behaviors that
resulted in higher HAART rates.
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Significance of Study
Adherence is defined as the “active, voluntary, and collaborative involvement of
the patient in a mutually acceptable course of behavior to produce a therapeutic result”
(Ho, Bryson, & Rumsfield, 2009, p. 3028). The contribution that this study made in
filling the gap for data and literature on adherence barriers to HAART is one that allows
the use of data from the study to highlight areas of improvement. This was utilized to
give insight on methods that reduced barriers for HAART and healthcare of African
Americans living with HIV/AIDS. This research impacts professional practice by
identifying what barriers exist so that behavior changes were addressed. Furthermore,
resources may be implemented to help those persons dealing with this issue to have the
knowledge and means to have compliance with their regimen of HAART. Additionally,
for the past decade, HIV prevention programs have started to emerge in the public health
sector as a means to decrease the spread of HIV infection (Fisher & Fisher, 2006).
Possible causes for medication noncompliance included reasons for medication
non-adherence inclusive to the individual being treated, socioeconomic status, type of
therapy, condition, and health system–related factors (Osterberg & Blaschke, 2005; Ho et
al., 2009). The findings of this research project can lead to positive social changes by
allowing African Americans living with HIV/AIDS to have an advanced quality of life
and lead to positive change by being able to improve their health. This presented
opportunity for these individuals to gain employment, sustain positive relationships, to
improve financial stability, present for follow up medical visits, and to even volunteer
with local public health agencies that are centered on HIV/AIDS as consumers.
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Summary
The impact of HAART adherence reaches beyond the scope of medical care.
HAART compliance influences social change and social position, personal and
professional relationships, financial stability, and quality of life. Having the ability to
identify, reduce or eliminate barriers of HAART adherence is definitely a positive
attribute. Knowing that successful HAART impacts clinical progression and, in most
cases, extends the longevity of life for persons living with HIV/AIDS on HAART, it is
critical that persons needing HAART have access to it and are able to have the tools and
resources to be successful while on it.
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Chapter 2: Literature Review
Introduction
Granted the pandemic of HIV/AIDS has existed over 30 years, challenges in
medical care continue to be cumbersome. This, in part, is due to the fact that health
problems vary by race and even by geographic areas. There is a decrease in the overall
number of HIV/AIDS cases; unfortunately, the number of African Americans diagnosed
with HIV/AIDS has not declined. In fact, Population Reference Bureau (2013)
highlighted that more African Americans are living with HIV or have already died from
AIDS in the United States than any other racial or ethnic group. While minorities in
general are underserved by the AIDS Drug Assistance Program (ADAP), of those
minorities; a majority are African American (Horneffer & Yang, 2013).
Highly active anti-retroviral therapy (HAART) has been successful in prolonging
life expectancy and decreasing the viral load of HIV in the human body (Cahill &
Valadez, 2013), but the use of HAART in the prevention of spreading HIV relies on
patient adherence and eliminating co-occurring sexually transmitted infections
(Kalichman et al., 2011). Primary care programs that put emphasis on HAART and
prevention requires persons to pay close attention to adherence, and sexually transmitted
co-infections (Kalichman et al., 2011). African Americans were 2.40 times more likely to
be noncompliant with HAART than Whites (Osborn, Paasche-Orlow, Davis, & Wolf,
2007).
The focus of this mixed-methods research was to determine what adherence
barriers exist to healthcare for African Americans infected with HIV/AIDS who were on
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HAART. This study helped to determine manners in which these barriers are reduced or
eliminated, resulting in improved compliance and HAART results.
Literature Search Strategy
Various types of resources were used to obtain information to construct this
literature review. Primarily peer-reviewed articles were obtained from databases and
search engines: Google Scholar, Academic Search Complete, PubMed, MEDLINE with
full text, Health & Medical Complete, Science Direct, ProQuest Central, and the Web of
Science. Key search terms individually and/or combinations such as HAART
compliance, HAART availability, access to healthcare for persons living with HIV/AIDS
and other opportunistic infections, HAART and comorbidities, HIV/AIDS in minorities,
the existence of ADAP, the quality of life of persons on HAART, AIDS Drug Assistance
Program (ADAP), HAART concerns, HAART cost, HAART financial assistance,
HIV/AIDS medical care, infectious disease medical treatment therapy, viral load, and
CD4 counts were used for these searches.
Literature Review
Impact of Socioeconomic Status and HAART Compliance
It was important to examine the health status of racial and ethnic subgroups
because different social groups, whether defined by marriage, gender, race or ethnicity
(Adler & Newman, 2002; Cohen et al., 2007); and even income, education, or region,
experience dramatically different levels of health (Cohen et al., 2007). It was important to
note that socioeconomic status (SES) is comprised of level of education completed,
occupation, financial stability, and income level (Friss & Sellers, 2004), and it is the most
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important predictor of health because all of these factors tend to be strongly associated
with each other (Schneider, 2006). For example, if children have parents or guardians that
are not financially stable, the children are directly impacted because they may lack proper
healthcare, housing, and nutrition. Therefore, it is important to make every effort possible
to make healthcare not only affordable, but also accessible.
Patient Assistance Programs/AIDS Drug Assistance Program
Although there is no cure for HIV/AIDS, treatments for HIV infection have been
successful in extending the lives of persons infected with HIV (Schneiderman, 2001).
Medications are not as harsh as they were when they were first introduced. As scientists
gained a better understanding of the virus, they were able to develop drugs that would
target the various stages of the replication process. Unfortunately, these medications are
very costly and the average person may not be able to afford them. However, programs
exist that assist people with paying for or getting their medication for little to no costs
known as Patient Assistance Programs (PAPs).
PAPs are pharmaceutical company plans that provide free medications to lowincome, uninsured, and underinsured people who need them. Persons who are eligible to
participate in PAPs must qualify. Each program is somewhat different for its specific
eligibility criteria. The following are general guidelines for most PAPs: (a) be a U.S.
citizen or legal resident; (b) have a doctor or other healthcare provider who can write
prescriptions and provide medical care for them; (c) cannot have any health insurance
that provides prescription coverage; (d) cannot be eligible for Medicaid, Medi-Cal (in
California), AIDS Drug Assistance Program (ADAP), or any other drug assistance
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program; and (e) must meet the annual income limits of the specific program (The Body,
2004).
Horneffer and Yang (2013) revealed that due to the expensive nature of HAART
medications, ADAPs were created to help offset the high costs of these medications
especially for low-income patients. In addition to funding sources such as pharmaceutical
vouchers and rebate programs, general revenue by states are needed for the continuation
of ADAPs because funds from the federal government no longer propel the program’s
budgetary growth (Kaiser Family Foundation, 2009). Regrettably, financial support for
ADAP has tapered over the past few years resulting in a waitlist for program enrollment,
formulary reductions for various medications and reduced coverage for HAART
(Horneffer & Yang, 2013). To further complicate issues, ADAPs were being inundated
by persons who needed financial assistance, and there was a rapid increase of persons on
the ADAP waiting list between the months of January 2010 through May 2011 (Figure
3). The number of persons on this list jumps from 361 to almost 7900 in less than 18
months (Knowledge Ecology International, 2011).
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Figure 3. ADAP waiting list enrollment between January 2010 and May 2011. This
graphs illustrates the increase in the number of HIV+ patients enrolled on the waiting lists
for ADAP (Knowledge Economy International, 2011 Dramatic increase in waiting lists
for AIDS Drug Assistance Programs, January 2010 to May 2011. Retrieved from
http://keionline.org/node/1128).
As could be expected with a decrease in funding, the length of the waitlist also
varies by states, and some states have cost containments measures that limit the amount
of funds that are available for ADAPs (Figure 4).
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Figure 4. ADAPs by state. This graph illustrates differences by state in ADAPs with
waiting lists and/or cost-containment measures (NASTAD, 2013).
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With the growth of the ADAP waiting list, there was also a growing
differentiation of race/ethnicities who were on the ADAP waiting list as of June 2013,
(The National Association of State and Territorial Apprenticeship Directors [NASTAD],
2013) (Figure 5). Approximately 64% of persons on the ADAP waiting list as of June
2013, were African Americans (NASTAD, 2013). This aligned with the excessive
prevalence of HIV/AIDS infections amongst African Americans who need HAART.
Typically, the higher incidences of HIV infections result in an increased need for persons
living with HIV/AIDS who are looking to prolong their life with HAART.

Figure 5. ADAP client waiting list by race/ethnicity as of June 2013. The graph
illustrates the percentage of HIV+ patients on ADAP waiting lists by race/ethnicity
(NASTAD, 2013).
Numerous academics and policy makers emphasize that those traditionally
underserved by ADAP, yet most affected by the HIV/AIDS epidemic, are minorities of
African American ethnicity (Horneffer & Yang, 2013). Not having access to ADAP
programs can hinder the inception or continued compliance of HAART. Underserved by
ADAPs and less likely to have insurance or medical coverage than Caucasians, African
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Americans typically receive coverage through Medicaid and may not consider other
means to receive HAART (Kahn, 2009).
Geographic Factors and HIV/AIDS Infection
Statistics show that ethnic minorities in the United States have significantly
higher mortality rates from most diseases than whites (Schneider, 2006). Trending an
estimated seven years, diagnosed HIV cases in the south have steadily increased in
heterosexual African American women and African American men who have sex with
men (MSM) (CDC, 2009; 2011). Despite the implementation of education and prevention
programs, HIV/AIDS cases to continue to progressively rise in the South.
Overall, states in the South have a higher mortality rate associated with HIV
(Figure 6). With data collected from the National Vital Statistics System and the National
HIV/AIDS reporting system, Hanna, Selik, Tang, and Gange (2012) completed a crosssectional analysis looking at mortality rates of persons infected with HIV living in 37
states between 2001 and 2007 and determined that nine of the ten states with the highest
mortality rates were located in the South (Hanna et al., 2012).
Furthermore, age-adjusted rates varied from 9.6 (95% CI 6.8–12.4) in Idaho to
32.9 (95% CI 29.8–36.0) in Mississippi, therefore demonstrating substantial disparities
across states, even after adjusting for race/ethnicity (p<0.0001) (Hanna et al., 2012).
These interstate differences in rates suggest differentiation in secondary and tertiary
prevention of HIV-related mortality among individuals living with HIV and imply that
state-specific contextual barriers to care may have a negative impact in quality and
disparities of health-care without targeted interventions (Hanna et al., 2012).
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Figure 6. Fatality rate per 1,000 persons in 2012. This figure is an illustration of HIV
mortality rates by state (Centers for Disease Control and Prevention, 2016).
Another study identified the Southeastern region of the United States as the core
of HIV/AIDS infections with HIV infection cases increasing faster than any other
national region (Hixson, Omer, del Rio, & Frew, 2011). It is, therefore, important to
understand why diseases are more prevalent in certain groups of people in different
geographic regions as a means of catering education and behavior modification programs
that effectively impact behavior change and could decrease disease infection rates.
Interestingly, Fowler-Brown, Ashkin, Corbie-Smith, Thaker, and Pathman (2006) shared

25
that minorities living with HIV/AIDS in the Southern region of the United States have
higher incidences of isolation and stigmatization. This may cause poor primary care
adherence if these persons do not seek treatment because of these emotions and fear of
disclosure.
Gender Variances
Gender is a construct that individually and in conjunction with other social factors
creates social norms that affect the behavior of men and women, provide various
protections and risks related to health, and shape institutional policies and practices that
privilege on gender over another (Cohen et al., 2007). Gender norms and values give rise
to gender inequalities, or differences between men and women that systematically
empower one group to the detriment of the other. Gender roles vary cross-culturally,
although the cultures produce particular systems of gender relations that affect life cycles,
roles, choices, and often inequalities in health (Lane & Cibula, 1999; WHO, 2014).
In 2010, one in four people infected with HIV in the United States were women
(CDC, 2014). Only 50% of women diagnosed were receiving medical care, with 40%
having the virus under control (CDC, 2014). Women are more likely to become infected
with HIV than men due to (a) a history of previous sexually transmitted infections which
increases the likelihood of HIV infection, (b) fear of partner abandonment if she insists
on condom use, (c) lack of knowledge about what their partners’ HIV infection high risk
behaviors are (such as injection drug use or having sex with other men) while engaging in
unprotected sex, (d) the risk being higher when engaging in anal sex than vaginal sex
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without a condom, and (e) having multiple partners and abusive partners who refuse to
use condoms during sex for those who have a prior history of sexual abuse (CDC, 2014).
Previous studies highlight the gender disparities seen in HIV infections rates of
white, black, and Hispanic/Latino men and women according to their sexual preference
and injectable drug use (IDU) (Figure 7), with white and black MSM had higher
infections rates than any other population (CDC, 2010). Oster et al. (2014) notes
although the MSM community is at the highest risk of HIV infection; large fringe and
central metropolitan areas experienced an elevated HIV rate in the MSM community.

Figure 7. Estimated HIV Infections in the United States for the Most-Affected
Subpopulations in 2010. This graph illustrates data obtained from the CDC in 2010
regarding estimated new HIV infections for the most-affected subpopulations (CDC,
2010). Abbreviations: MSM, men who have sex with men; IDU, injection drug user.
A prospective, longitudinal study completed by Heffron et al. (2011) evaluating
3,790 heterosexual HIV-1-serodiscordant couples (where one partner is HIV negative
and the other is HIV positive) and compared for HIV-1 acquisition by women and HIV-1
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transmission from women to men to analyze the implication contraceptive use on HIV-1
risk. The female participants either used condoms, oral and injectable contraceptives or
were not using any form of contraception. Rates of HIV acquisition were 6.61 per 100
person-years in women who used hormonal contraception and 3.78 per 100 person-years
in those who did not use any form of hormonal contraception in cases where the female
was negative for HIV (adjusted hazard ratio 1.98, 95% CI 1.06 -3.68, p = 0.03) (Heffron
et al., 2011). Conversely, rates of HIV transmission from women to men were 2.61 per
100 person-years in couples in which women used hormonal contraception and 1.51 per
100 person-years in couples in which women did not use hormonal contraception
(adjusted hazard ratio 1·97, 95% CI 1·12—3·45, p = 0·02) (Heffron et al., 2011). The
results of this study indicated that behaviors associated with contraceptive use may be a
factor in the rate of HIV and STI transmission (Heffron et al., 2011).
Meditz et al. (2011) collected and analyzed data from individuals that were
primarily North American cohort of HIV-1 Seroconverters (HIV-infected persons who
have had a negative antibody test within 3 years of their first antibody positive test).
Although women were more advantageous in clinical parameters than men, women
experienced more critical outcomes than male seroconverters. Blatant morbidity was
supplemental with being nonwhite and residing in the southern United States (Meditz et
al., 2011).
When gender is addressed in the HIV/AIDS community, the transgender
population is also impacted by the HIV/AIDS pandemic. The term transgender pertains to
the gender, not the sexual orientation with which a person identities; transgendered
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people can be gay or lesbian, heterosexual, or bisexual (MacKenzie, 1994). There is no
national surveillance data currently available on the incidence or prevalence of
HIV/AIDS within the U.S. transgender population; however, data collected by local
jurisdictions suggest disproportionately high rates of HIV infection among transgender
persons.
In 2002, the State of California began recording male-to-female (MTF) and
female-to-male (FTM) as gender reporting options in publicly-funded HIV counseling
and testing sites. Despite accounting for a small proportion of the population, data
collected in 2003 revealed that self-identified transgender clients had a much higher rate
of HIV diagnoses (6.3%) than other risk categories, including men who have sex with
men (MSM; 4.2%) or partners of people living with HIV (4.8%) (Herbst et al., 2008).
This data also revealed that MTF African American transgender clients had a
substantially higher rate of HIV diagnoses than all other racial or ethnic groups (Herbst et
al., 2008).
A transgendered person’s risk for HIV/AIDS from IV drug use is also a concern;
however, the extent to which IV drug use is a factor in the transmission of HIV in the
transgender community is not clear. HIV infection might be the result of a combination
of IV drug use and sexual activity. It is very likely that alcohol and drugs are being used
to decrease one’s inhibition to engage in high-risk sexual activity (Kenagy, 2002). Lack
of AIDS knowledge may also be a risk factor for HIV infection among transgendered
people. The amount of information available is limited, but research seems to suggest that
MTF transgendered people have lower levels of AIDS knowledge than other non-
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transgendered groups (Kok et al., 1990). CDC (2015b) reports grander rates of newly
diagnosed HIV infections were among black/African American transgender women
(56.3%) versus white (16.7%) or Latina (16.1%) transgender women.
Those identifying as transgender often experiment with their own sexual
orientations and attractions. In addition, many are involved in money for sex in an effort
to support substance addictions or to make money for the purchase of necessary
hormonal therapy. Some reuse or share needles to inject their hormones because of the
insurance industry's unwillingness to cover hormonal therapy. Like any population, these
sexual behaviors and sharing of needles increase HIV transmission risk (Cichocki, 2007).
HIV prevention efforts must take into consideration the complexity of their sexual
orientation. Sexual orientation of transgendered persons is not well documented in the
literature and at times seems to be confused with gender identity. Because of disclosure
fears and risks, identifying and finding the transgender community is difficult. This in
turn makes it difficult to target prevention messages to the transgender community. In
addition, prevention messages are often biased according to gender. If one does not
identify as that gender, the prevention message may not be received at all (Cichocki,
2007). Public health officials must be able to understand the special needs of this
population and make certain that education and prevention efforts are implemented to
meet the needs of this particular group.
Disproportionately afflicting minorities, HIV continues to present as a formidable
challenge altering the social geography of families across generations (Colasanti,
Nguyen, Kiem, Deeb, & Jayaweera, 2012). When a parent is infected with HIV/AIDS,
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the quality of their health may have a direct impact on the dynamics of their family.
These dynamics may result in an increased responsibility load for children in the home.
Similarly, children living with HIV/AIDS may have unique barriers of their own.
Children and HAART
To date, few studies have been conducted relating to children and HAART and
not much is known about specific barriers or successes for HAART among children.
Buchanan et al. (2012) completed a longitudinal sub-study of a multicenter cohort study
between 2000 and 2007 in the Unites States that tracked HIV-infected and uninfected,
perinatally HIV-exposed children between the ages of 8 years and 19 years old and
focused on the perceptions of caregivers and barriers associated with HAART adherence
for the HIV positive youth and children they are caring for (Buchanan et al., 2012). The
researchers noted anytime nonadherence ensues after an HIV/AIDS diagnosis and the
start of HAART, there was a high probability of treatment failure and even resistance.
Because children depend on someone else to assist with their HAART, they experience
different barriers (Figure 8) than many adults (Figure 9), with logistic issues being the
most common barrier reported by both (Buchanan et al., 2012). This early experience
with nonadherence is a concern as it opens the door for swift disease progression and
other possible health issues (Buchanan et al., 2012). Limitations with this study were that
the surveys completed did not specifically mention HIV/AIDS medications or HIV/AIDS
status, so it is a possibility that children included non-HAART medications in answering
their questions (Buchanan et al., 2012).
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Figure 8. Child-reported barriers to adherence. This graph is an illustration of the types of
barriers reported by children and their relative frequency (in percentage). Most children
forgot to take their medication, with the second most common barrier being oversleeping
(Buchanan et al., 2012).
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Figure 9. Caregiver-reported barriers to adherence. This graph is an illustration of the
types of barriers reported by adults and their relative frequency (in percentage). Most
adults forgot to give their children medication, with the second most common barrier
being a change in the daily routine (Buchanan et al., 2012).
Guidelines for Implementing HAART
In general, persons living with HIV/AIDS are either treatment-naïve or treatmentexperienced. Treatment-naïve refers to a person living with HIV/AIDS that has never
been on HAART, while treatment-experienced refers to a person living with HIV/AIDS
that has been on, or is currently taking HAART (AIDS Info, 2011). It has been shown
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that early treatment with HAART is very effective in treating persons living with
HIV/AIDS (Gulick, 2010). In fact, since the introduction of HAART, there has been a
significant decrease in the number of persons dying from AIDS-related deaths (Figure
10).

Figure 10. Number of HIV related deaths and number of persons living with HIV, 19812007. This figure illustrates the impact of HAART treatment on HIV infection and AIDSrelated deaths (National Institute of Drug Abuse, 2012).
Modified clinical guidelines for initiating HAART earlier in the course of HIV
infection have shown benefits relating to improved health and decrease of illness
occurrences (Department of Health and Human Services [DHHS], 2011). These modified
guidelines, which were implemented in 2013, encourage an earlier start on HAART and
directly impacted the number of persons eligible for HAART to increase to 9.2 million
(AVERting HIV and AIDS [AVERT], 2014). Morin et al. (2011) emphasized guidelines
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for initiating HAART have also shifted toward commencing prescription therapy at
higher CD4 cell counts, with the goal of total HIV viral suppression, also known as an
undetectable viral load.
As of lately, many clinicians agreed HAART should be recommended for all
HIV-infected individuals, irrespective of their clinical status, at the time of diagnosis in
order to improve long-term health outcomes (DHHS, 2011).
Mills et al. (2006) stated the following:
Adherence to antiretroviral therapy is a powerful predictor of survival for
individuals living with human immunodeficiency virus (HIV) and AIDS. HAART
adherence of 95% is a target goal; however, HAART adherence is much lower….
Concerns about incomplete adherence among patients living in poverty have been
an important consideration in expanding the access to antiretroviral therapy. (p.
679)
Unfortunately, while clinicians and researchers are aware of the importance of
early medical care and HAART, not all HIV infected persons share those feelings and
place emphasis on the disadvantages of HAART (Beer et al., 2012). Therefore, it is
imperative that clinicians providing medical care to persons on HAART discuss any
issues with mistrust of the medical system and religious beliefs that may impact
compliance (Gaston & Alleyne-Green, 2012). Another possible reason for
noncompliance is complexity of treatment. Stone et al. (2001) noted there is a greater rate
of self-reported adherence among persons whose HAART is less complicated than other
prescription therapy. The more complex a person’s HAART is, the less likely they are to
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grasp details of all of the components of HAART. The HIV Causal Collaboration (2011)
documented that persons who are compliant with their prescription regimen experience a
higher rate of healthy living and lower healthcare expenses during their lifetime since
they are less likely to access medical care than those persons who are less compliant with
their prescription regimen (Fleishman et al., 2010). Likewise, Kelly and Kalichman
(2002) acknowledged HAART nonadherence destabilizes the possibility of reduction in
HIV transmission.
Comorbidities & HIV/AIDS Infection
Persons living with HIV/AIDS, who are co-infected with other communicable
diseases, have a higher probability of a decline in their CD4 cells. Kelly and Kalichman
(2002) highlighted that secondary preventive efforts are focused on preventing any
occurrence of opportunistic infections and adverse events for persons living with
HIV/AIDS. Taye and Lakew (2013) demonstrated that co-infection with Hepatitis C
(HCV) resulted in a rapid decrease of a person’s CD4 and CD8 cells; higher CD4 and
CD8 counts typically mean that a person is healthier and less likely to be as sick.
Adherence to HAART decreases the likelihood of lower CD4 and CD8 counts (Taye &
Lakew, 2013).
Theoretical Foundation
For this study, the health belief model (HBM) was the theoretical framework.
This model was applicable because an individual’s perceptions and/ or beliefs had a
direct impact on strategies that may decrease disease occurrence (Glanz et al., 2002).
These perceptions included seriousness, benefits, barriers and susceptibility (Glanz et al.,
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2002). The aforementioned perceptions had a positive or negative influence on a person’s
health. Individuals who are living with HIV/AIDS who were on HAART may have
looked at this part of their medical care as either beneficial or harmful, due to some of the
possible side effects of the medication. Any negative perceptions reduced compliance
with HAART.
The HBM was developed in the 1950s as a method to describe why medical
screening programs offered by the U.S. Public Health Service were having poor success
rates (Hochbaum, 1958). The HBM is the most utilized theory in health education and
health promotion (Glanz et al., 2002; National Cancer Institute [NCI], 2003).
eMedOnline (2012) incorporated theoretical models that define health beliefs and
behaviors associated to adherence, which is defined as compliance plus persistency, to
create a telehealth platform involving medication and disease presentation; illness
representation; individual difference; medication adherence; cognitive function; and
external cues (Figure 11).
The platform focused on the perception of threats posed by the disease; belief that
adherence ameliorated the risk; complexity, interval, safety, efficacy, accessibility and
financial impact of medication; and patient-doctor relationship, and it highlights concerns
of a patient's sense of participation in being empowered about decisions impacting their
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therapy (EMedonline, 2012).

Figure 11. Medication adherence telehealth platform. This figure demonstrates health
beliefs and behaviors associated to adherence (eMedOnline, 2012).
Schneiderman (1999) stated psychosocial treatment studies provide a method for
conducting causal investigations within a clinical environment. They can also inform the
researcher about relationships between psychosocial or bio-behavioral processes on the
one hand and disease on the other. Stone (2011) highlighted that minorities have a very
low rate of medical care and HAART compliance than others living with HIV/AIDS;
some of the barriers facing minorities living with HIV/AIDS that impact their adherence
values are (a) lack of financial stability, (b) side effects of the medication, (c) mobility,
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(d) mental health and substance abuse issues, (e) expediency, and (f) poor support team
of family and friends (Konkle-Parker et al.,2 007). Therefore, a qualitative approach to
understand these barriers is equally necessary.
Summary
Although interest in the global expansion of HAART under the context of HIV
treatment as prevention (TasP) has been reintroduced, a population-level sustainability of
this strategy has not been documented (Julio et al., 2014). Rodrigues (2008) noted the
Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of
2008 was signed to allocate a sum of $50 billion to the President’s Emergency Plan for
AIDS Relief (PEPFAR) and other health programs. There must be proper use of funds in
order to reach the masses of people that need treatment.
Proper healthcare and compliance with HAART, safer sex methods and behavior
changes are all ways to reduce the harsh impact that HIV/AIDS can have upon the human
body. Previous research studies already revealed that expanding HAART has contributed
to a decrease in morbidity, mortality and HIV transmission (Julio et al., 2014), but Reed
at al. (2009) shares that 28% of HIV infected persons from 18 states during 2000 and
2004, were not linked to care within three month of finding out their HIV stats. This is
considered delayed entry into care. Entrance into care needs to be as easy as possible.
This failure to link patients to care is of concern, because it has shown that the
sooner that a person with HIV/AIDS starts HAART, the more likely they are to improve
their health and prevent additional comorbidities or a decline in CD4 counts or increase
in viral loads (Beer et al, 2012). While HAART enrollment and compliance is an issue

39
for a number of reasons previously discussed (e.g., location of medical facility,
enrollment requirements, and financial cost play a vital role in adherence), this is a
particular challenge when one considers the many disparities faced by the African
American community.
As previously discussed in this chapter, Population Reference Bureau (2013)
highlighted that more African Americans are living with HIV or have already died from
AIDS in the United States than any other racial or ethnic group. Minorities, especially
African Americans, are underserved by the AIDS Drug Assistance Program (ADAP)
(Horneffer & Yang, 2013), and continue to experience significant imbalances in medical
care, linkage to care, and HAART implementation (Stone et al., 2009). The current
themes in the literature pertaining to African Americans and HAART compliance
resonate with the commonalities of barriers being access to care, financial concerns,
comorbidities, and poor behavior choices that increase the risk of HAART success due to
other lifestyle issues such as drugs, or homelessness.
Recent procedures such as testing and treating early on when a person is
diagnosed with HIV, focusing on linkage to care, retention of medical care, and
prevention hold great promise for women and minorities with HIV in the U.S. (Stone,
2011). Although these forms of intervention are promising, Morin et al. (2011)
communicated that implementing multilevel interventions and evaluation of the
HIV/AIDS epidemic impact poses challenges to traditional research paradigms because
they do not consider evaluation and efficiency of studies that respond to implementation
challenges (Morin et al., 2011). This study filled the gap in terms of implementation
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challenges that may be thwarting multilevel interventions by identifying adherence
barriers to healthcare for African Americans with HIV/AIDS on antiretroviral
medications.
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Chapter 3: Research Method
Introduction
The findings of this research project can lead to social changes by affording
African Americans living with HIV/AIDS an advanced quality of life. This spearheaded
change by being able to improve their health through access to healthcare by proposing
solutions capable of limiting barriers affecting their compliance with their planned
treatment regimen. This presented opportunity for these individuals to gain employment,
sustain relationships, improve financial stability, be present for follow up medical visits,
and volunteer with local public health agencies that are geared towards persons infected
with HIV/AIDS as consumers. Having the capacity to be an asset and productive citizen
in their community had a ripple effect when their family, friends or coworkers see this
behavior that led to a positive economic impact as well. Individually and collectively
these indicators impacted social change in a progressive manner.
Setting of the Study
AID Atlanta, Inc. and Fulton County Health and Wellness are the two nonprofit
agencies that will be essential in conducting this research. Servicing persons living with
HIV/AIDS since its inception in 1982, AID Atlanta, Inc. continues to prove itself as a
leader in the battle against HIV/AIDS in metropolitan Atlanta and is the Southeast’s
oldest, largest, and most comprehensive AIDS Service Organization (ASO) (AID
Atlanta, Inc., 2014). The mission of AID Atlanta, Inc. is to reduce new HIV infections
and improve the quality of life of its members and the community by breaking barriers
and building community by providing primary healthcare services, AIDS Drug
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Assistance Program (ADAP) assistance, case management, a linkage and retention to
care program, and educational programs (AID Atlanta Inc., 2014).
Fulton County Health and Wellness HIV/AIDS Primary Care Clinic is a Ryan
White funded public health center that offers services for persons living with HIV (Fulton
County Georgia, 2011). Services at the clinic range from primary medical care services,
dental services, case management, ADAP assistance, educational and behavioral health
services, Tuberculosis screening and treatment, STD medical care screening and
treatment, and linkage and retention services (Fulton County Georgia, 2011). At present
their primary care clinic has more than 1,100 active clients who receive services.
Surveys were given to study participants at ADAP appointments and medical
visits. I escorted study participants to a private exam room or clinician office to complete
their surveys. All surveys were collected by me daily.
Research Design and Rationale
By using mixed methods, I was able to collect data from surveys that participants
completed, and was able to analyze data inclusive of multilevel perspectives. I collected
quantitative and qualitative data concurrently; I used the convergent mixed-method
design. I chose this type because I analyzed the two data sets separately and then merged
the results during interpretation.
Overall, I chose this method to capture multidimensional intelligence that
produced a well-defined understanding of HAART compliance through data on
behaviors, emotions and existing barriers. My study benefited from both of these
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methods, which is why I selected the mixed methods route using primarily qualitative
methods.
Research Questions and Hypotheses
There were four research questions in this study: two qualitative and two
quantitative. The qualitative questions encompassed information that the clients shared
about barriers to HAART and what their personal experiences have been.
The quantitative questions focused on the level of compliance with HAART and
medical care. The quantitative questions helped to generate additional responses that
further supported the qualitative research element of this study.
Qualitative Research Questions
RQ 1. What are the barriers causing African Americans living who with
HIV/AIDS to have lower adherence rates with HAART than persons of other ethnic
groups?
RQ 2. How can barriers for medical treatment of African Americans living with
HIV/AIDS be eliminated?
Quantitative Research Questions
RQ 3. Will attending two primary care visits within six months of being linked to
care increase the rate of compliance for African Americans on HAART living with
HIV/AIDS?
H01: Attending two primary care visits within six months of being linked to care
will not increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
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HA1: Attending two primary care visits within six months of being linked to care
will increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
RQ 4. Will African Americans living with HIV/AIDS who have been out of care
for 12 or more months have a low linkage to care rate?
H02: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will not have a low linkage to care rate.
HA2: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will have a low linkage to care rate.
Concept of Study
The central concept of this study was being successfully linked to care may have a
direct impact on HAART compliance and retention to care. If successful, a person living
with HIV/AIDS will have a better quality of life due to improved health, and, in turn, will
be able to have more productive lives and have an impact on positive social change. As
far as HAART is concerned though, several variables have a potential impact on HAART
compliance as it relates to the concept of this study (Figure 12).
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Figure 12. Concept of study variables that may impact HAART. The graph represents the
different variables that may affect a person’s decision to remain compliant with HAART
treatment following a diagnosis of HIV+ and subsequent enrollment in HAART regimen.
Role of the Researcher
I served as the investigator in this research study. As the investigator, I had a
direct encounter with clients by asking them to complete surveys and by collecting the
surveys when participants completed them each day. When a study participant agreed to
participate in the research study, I escorted them to a private office and gave them the
consent form to read and study survey to complete. If desired, study participants kept a
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copy of the consent form. My relationship with the clients remained professional at all
times.
As a manager working at the Fulton County Health and Wellness HIV/AIDS
Primary Care Clinic, part of my duties was to manage the day to day operations in the
clinic. This included working closely with physicians, physician assistants, nurses,
behavioral health clinicians, a psychologist, case managers and ADAP coordinators. I did
not have any personal relationships with any of the clients. Their role as a participant had
no direct impact on their day to day work functions or professional expectations and
duties. The outcome and validity of data collected was not impacted by the role of anyone
at the Fulton County Health and Wellness HIV/AIDS Primary Care Clinic. Once the
study concluded all completed surveys were stored in a locked file cabinet and will
remain there for five years, as required, and then they will be destroyed.
Methodology
Participant Selection Logic
Maxwell (1997) shares that purposive sampling is a sampling type by which
‘‘particular settings, persons, or events are deliberately selected for the important
information they can provide that cannot be gotten as well from other choices’’ (p. 87).
The target population for this study was 45-55 African Americans living with HIV/AIDS
that have been, or are taking HAART and that are presently receiving medical care for
their HIV/AIDS. The sampling strategy used was to identify clients who were on ADAP
and coming into the clinic for their 6-month recertification visit. Additionally, the
selection logic was designed to address the qualitative focus and collect limited data on
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the quantitative elements of the study that will influence qualitative findings. There were
some quantitative questions that were not answered unless “yes” was a response. These
questions led to answers that supported qualitative data findings of this research study.
The criteria for participant selection were that a person must be infected with
HIV/AIDS. In order to be a patient at the Ryan White clinic or AID Atlanta, Inc. a person
had to be infected with HIV or have an AIDS diagnosis. Clients also had to be (a)
receiving medical care for their HIV infection, (b) 18 years of age or older, and (c) be
HAART experienced. With the new recommendations of the implementation of HAART
almost all of the clients at these two clinics had HAART experience. The relationship
between saturation and sample size was not a major concern. Saturation happened due to
the nature of the study participants being infected with HIV/AIDS and having some sort
of experience with HAART.
Instrumentation
Quantitative/Qualitative Components
Excluding demographic information, the survey tool (Appendix A) consisted of
12 questions that study participants answered. There were two open ended (qualitative)
questions and 10 multiple choice questions (quantitative). The quantitative questions
supported the qualitative focus of this research study. The multiple-choice questions
helped to identify any trends in the collected data. Based upon this mixed use of
questions, a mixed method analysis was appropriate. I used the Southeast AIDS Training
and Education Center (SEATEC) survey for the Georgia Statewide Client Satisfaction
survey as a reference in creating my survey.
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The SEATEC survey was administered at AIDS service organizations around
Georgia, including Fulton County Health & Wellness and AID Atlanta, Inc. Given the
wide use of this survey, it was safe to assume the original survey tool was tested for
validity and reliability before allowing agencies to use it in order to collect data from
their clients. All electronic and paper survey data collected by SEATEC was cleaned and
analyzed in aggregate and by agency using IBM SPSS (version 21.0) and Microsoft
Excel (version 2013).
The self-administered survey (a) required less time than face to face interviews,
(b) was cost efficient, (c) allowed the client privacy assurance, and (d) encouraged clients
to answer delicate personal questions (Singleton & Straits, 2002).
Participation and Data Collection
Case managers and ADAP coordinators had daily appointments scheduled with
clients living with HIV/AIDS. At these appointments, AID Atlanta, Inc. case managers
and ADAP coordinators assisted in passing out flyers for the research study. These flyers
had my contact information and information about the study on it. Each participant
completed a consent form acknowledging their willingness to participate in this study by
completing the survey. When a study participant agreed to participate in the research
study, I placed them in a private office and gave them the consent form to read and study
survey to complete. If desired, study participants kept a copy of the consent form. The
consent form was the cover page for the survey. I was always available to discuss the
study and collect data onsite for all study participants.
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I will keep all raw data and completed surveys in a locked file cabinet in my home
office for five years. No follow up contact is needed with the study participants. All of
the data was collected and put into SPSS and analyzed I collected both quantitative and
qualitative data concurrently (parallel form).
Threats to Validity
SEATEC had previously tested the original survey for reliability and validity. The
only possible threat of validity in this research study may be clients not completing every
question of the survey. The importance of this will be stressed at the beginning of the
survey and again, after the clients finishes the survey. They will be asked to ensure each
question has been answered. Talbert (2007) noted that research studies steered to assess
behaviors are most effective for quantitative analysis of descriptive data.
Furthermore, threats to internal validity will be eliminated because there will be
no design contamination with the survey. Compensatory rivalry will not be an issue
because there will be no goods or services exchanged for study participation, and
selection criteria will not change. Threats to external validity will be reduced because
there will be no selection bias, experimental treatment, or physical performance
experiments conducted.
Ethical Procedures
Ethical procedures of this research study were to ensure that each survey
completed was anonymous and that no identifying information was captured as part of
the survey. Laws and policies were in place to help protect the health of all persons by
controlling the occurrence of diseases and prevention and treatment for the masses.
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I obtained approval from the Walden University Institutional Review Boards (IRB
#07-12-16-0134863) and letters of cooperation from the target agencies (Appendix B &

C) prior to collecting any data. There was a cover page to the survey that served as the
consent page. This page told the clients about the survey, what their results are to be used
for and to obtain their consent. The survey was anonymous. I did not use this survey to
report HIV/AIDS status or diagnosis. There were no physical or mental risks to any of the
survey participants. Study participants were not asked to take any additional medications
than what they were currently taking in their HAART regimen. Additionally, no study
participants were asked or required to start taking HAART for participation in this study.
Data collected will be kept in a locked file cabinet and I will be the only person with
access to the completed surveys.
Data Analysis Plan
The selected data analysis describes the statistical procedure utilized to answer the
research questions selected for this study. The data collected for this single research study
was qualitative and quantitative in nature. Creswell (2009) noted the use of mixing data
sets will allow a clearer understanding of the research problem than if just one was used
alone.
Once all completed surveys had been received, I organized the data. Qualitative
and quantitative data was separated. Serving as the primary component of this study, I
analyzed my qualitative data results from both open-ended questions by grouping results
into themes. I looked for similarities and differences to assess if there was a significant
relationship between disparate barriers of HAART adherence rates and barriers for
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medical care. Each response was given a code making it possible to analyze the
frequency of repeated answers. I coded the common answers by name and group/code
the less common answers as “other.”
Being able to capture responses to open ended questions on the survey tool did
not present a problem with this program. The open ended qualitative questions asked
about barriers they have experienced that interfered with their medical care and
compliance to their HAART regimen.
Upon the completion of data collection and evaluation, quantitative data was
imported into SPSS (version 21.0) software program. To ensure the process of importing
data was successful, all imported data was verified by data cleaning to ensure the validity
of data. Nominal data such as gender was assigned a numeric value for analysis. The
gender selections included male, female, and transgender.
Descriptive statistics in latest version SPSS (version 21.0) software program was
used in order to analyze data collected from study participants. SPSS (version 21.0) was
utilized to perform multiple linear regression analyses that will measure the impact of
HAART compliance, linkage to care rates, and existing barriers. Hypothesis testing was
conducted using linear multiple regression as well to show the degree of dependent
variables and the prediction of independent variables.
Survey Design
Qualitative Research Questions
RQ 1. What are the barriers causing African Americans living who with HIV/AIDS
to have lower adherence rates with HAART than persons of other ethnic groups?
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Survey question #7 asks the participant what options/barriers caused then to stop
HAART.



Survey question #10 asks the participant to share what barriers interfere with their
medical care.
RQ 2. How can barriers for medical treatment of African Americans living with

HIV/AIDS be eliminated?


Survey question #10 asks the participant to share what barriers interfere with their
medical care.



Survey question #11 asks the study participants can barriers for medical treatment
for HIV/AIDS be eliminated.



Survey question #12 asks the participant are they pleased with their prescription
therapy they are taking at the moment.

Quantitative Research Questions
RQ 3. Will attending two primary care visits within six months of being linked to
care increase the rate of compliance for African Americans on HAART living with
HIV/AIDS?


Survey question #1 asks how long has a participant been in medical care for
HIV.



Survey question #2 asks the participant how long have they been on HAART.



Survey question #8 asks the participant have they been able to attend two
primary care visits within the past six months.
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RQ 4. Will African Americans living with HIV/AIDS who have been out of care
for 12 or more months have a low linkage to care success rate?


Survey question #2 asks the participant how long have they been on
prescription therapy (HAART).



Survey question #3 asks the individual have they ever been out of care for
more than 12 months.



Survey questions #4 and #5 are only answered if the participant said yes to
survey question #3.



Survey question #6 asks the participants if being in medical care on a regular
basis (at least 12 months) helped with HAART compliance.



Survey question #8 asks the participant have they attended 2 primary care
visits within the past 12 months.
Summary

This chapter focused on the use of the mixed research methodology for this
particular research study. The logic of this study assessed the impact of barriers to
HAART compliance and linkage to care for persons infected with HIV/AIDS. This
chapter focused on the setting of the study, theoretical foundation, research design and
rationale, role of the researcher in the study, methodology, collecting my own data,
threats to validity, and ethical procedures that must be considered.
Chapter 4 will focus on data collection, data analysis, study results and
trustworthiness. Chapter 5 will have topics of discussion, conclusions, and
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recommendations on HAART, ways to improve linkage to care, eliminating, and
reducing barriers to HAART and medical care.
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Chapter 4: Results
Introduction
The main objective of this research study was to determine what where the
existing adherence barriers to healthcare for African Americans with HIV/AIDS that
were taking HAART. I assessed a group of adult minorities living with HIV/AIDS that
were taking HAART. I investigated how existing barriers have impacted adherence to
HAART. The purpose of Chapter 4 is to present the results of statistical analyses from
the data collected using the research design presented in Chapter 3. In this particular
chapter, I will describe the findings of this mixed methods approach, primarily qualitative
study, question by question. I will discuss the interpretation of the study results,
conclusions and recommendations for further research in Chapter 5.
Research Questions and Hypotheses
The study was conducted to answer the following research questions and test the
hypotheses of the questions.
Qualitative Research Questions
RQ1. What are the barriers causing African Americans living with HIV/AIDS to
have lower adherence rates with HAART than persons of other ethnic groups?
RQ2. How can barriers for medical treatment of African Americans living with
HIV/AIDS be eliminated?
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Quantitative Research Questions
RQ3. Will attending two primary care visits within six months of being linked to
care increase the rate of compliance for African Americans on HAART living with
HIV/AIDS?
H01: Attending two primary care visits within six months of being linked to care
will not increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
HA1: Attending two primary care visits within six months of being linked to care
will increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
RQ4. Will African Americans living with HIV/AIDS who have been out of care
for 12 or more months have a low linkage to care rate?
H02: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will not have a low linkage to care rate.
HA2: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will have a low linkage to care rate.
Community Partners and Setting of the Research Study
AID Atlanta, Inc. and Fulton County Health & Wellness are the two nonprofit
agencies that were essential in conducting this research. Servicing persons living with
HIV/AIDS since its inception in 1982, AID Atlanta, Inc. continues to prove itself as a
leader in the battle against HIV/AIDS in metropolitan Atlanta and is the Southeast’s
oldest, largest, and most comprehensive AIDS Service Organization (ASO) (AID
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Atlanta, Inc., 2014). The mission of AID Atlanta, Inc. is to reduce new HIV infections
and improve the quality of life of its members and the community by breaking barriers
and building community by providing primary healthcare services, AIDS Drug
Assistance Program (ADAP) assistance, case management, a linkage and retention to
care program, and educational programs (AID Atlanta Inc., 2014).
Fulton County Health and Wellness HIV/AIDS Primary Care Clinic is a Ryan
White funded public health center that offers services for persons living with HIV (Fulton
County Georgia, 2011). Services at the clinic range from primary medical care services,
HAART, dental services, case management, ADAP assistance, educational and
behavioral health services, Tuberculosis screening and treatment, STD medical care
screening and treatment, and linkage and retention services (Fulton County Georgia,
2011).
Data Collection
Case managers and ADAP coordinators had daily appointments scheduled with
clients living with HIV/AIDS. At these appointments, AID Atlanta, Inc. case managers
and ADAP coordinators assisted in passing out flyers for the research study. These flyers
had my contact information and information about the research study on it.
When a study participant spoke to me face to face, or contacted me and agreed to
participate in the research study, they were placed in a private office and were given a
consent form to read that explained the qualifications for participants, the purpose of the
study, procedures and duration, sample questions, volunteer nature of the study, risks and
benefits of being in the study, lack of payment compensation, privacy, and contact
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information. The participant consent form acknowledged their agreement to participant in
the study. If desired, study participants kept a copy of the consent form. This consent
form was the cover page for the survey. Once the study participants gave their consent to
participate they were given an anonymous survey to complete. Once the surveys were
completed, I collected them and placed them in a locked file cabinet daily. No one else
had access to the surveys.
Data Analysis
This data analysis plan explains the results of descriptive statistics and linear
regressions that was used to answer the research questions selected for this study. The
data collected for this single research study was qualitative and quantitative in nature.
Once all completed surveys were received, I organized the data. Qualitative and
quantitative data was separated. Serving as the primary component of my study, I
analyzed my qualitative data results from both open-ended questions by grouping results
into themes. In order to analyze the qualitative data to this survey I tracked themes in
which there was a repetition of words. These were words that the survey respondents
used a lot to answer the survey questions.
Using SPSS (version 21), I was able to generate a list of all the unique words in a
text and I counted the amount of times each word occurred. Having a word frequency list
made it very straightforward to look at the categories that were forming from the theme
word frequency. I looked for similarities and differences to assess if there is a significant
relationship between disparate barriers of HAART adherence rates and barriers for
medical care. Each response was given a code making it possible to analyze the
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frequency of repeated answers. I coded the common answers by name and group code
the less common answers were coded as “other.”
Upon the completion of data collection and evaluation, quantitative data was
imported into SPSS (version 21.0) software program. To ensure the process of importing
data was successful, all imported data was verified and cleaned to ensure the validity of
data. I used descriptive statistics in SPSS (version 21.0) software program in order to
analyze data collected from study participants. SPSS (version 21.0) was utilized to
perform multiple linear regression analyses on quantitative data that measured the impact
of HAART compliance, linkage to care rates, and existing barriers.
Descriptive Statistics Demographics of Study Participants
The target population for this study was African Americans living with
HIV/AIDS that have been, or are taking HAART and presently receiving medical care for
their HIV/AIDS. In order to be a patient at the Ryan White clinic or AID Atlanta, Inc. a
person had to be infected with HIV or have an AIDS diagnosis. Clients must also have
been (a) receiving medical care for their HIV infection, (b) 18 years of age or older, and
(c) be HAART experienced.
Gender, Age and Marital Status of Study Participants
Of the 51 study participant’s a majority, 30 (58.8%), were male. There were 15
(29.4%) female and 6 (11.8%) transgender study participants (Table 1). The age of study
participants ranged from 18 years of age to persons 60 and above (Figure 13). The
majority of study participants (n = 19) were between the ages 30-39 years (37.3%),
followed by 14 participants between 40-49 years of age (27.5%) (Figure 13). Shown in
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Table 2 and Figure 14, the majority of the study participants (n=34; 66.7%) were single
followed by married (n = 9; 17.6%).
Table 1
Gender of Study Participants
What is your gender?
Frequency Percent

Valid

Male

30

58.8

Female

15

29.4

6

11.8

51

100.0

Transgender
Total

Figure 13. Age in years of study participants.

Valid
Percent
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Table 2
Marital Status of Study Participants
What is your marital status?
Single

Valid

Frequency Percent
34
66.7

Married

9

17.6

Widowed

3

5.9

Divorced

3

5.9

Separated

2

3.9

51

100.0

Total

Figure 14. Marital status of study participants

62

Medical Care and Prescription Therapy Experience
Medical Care Duration
Thirteen study participants (25.5%) had been in care 6-10 years, followed by 12
participants (23.5%) that had been in care 3-5 years. An equal number (10) of study
participants had been in medical care 3-5 years and 16 or more years (Table 3). In care 16
or more years were 6 of 51 study participants (Table 3).
Table 3.
Duration of medical care in years
How long have you been in medical care?

Valid

1-2

Frequency
12

Percent
23.5

3-5

10

19.6

6-10

13

25.5

11-15

6

11.8

16 or more

10

19.6

Total

51

100.0

Prescription Therapy Experience
Looking at the duration of prescription therapy for study participants, Table 4 and
Figure 15, show that majority of study participants, 16 participants (31.4%), were on
prescription therapy 1-2 years, followed by 12 participants (23.5%) that were on
prescription therapy 3-5 years. Comparing these statistics with the 7 participants (13.7%)
on prescription therapy 16 or more years, there is a large gap of approximately 24%
between those that were on prescription therapy the shortest and longest duration.
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Table 4
Duration of prescription therapy experience in years
How long have you been on prescription therapy?
1-2

Valid

Frequency Percent
16
31.4

3-5

12

23.5

6-10

7

13.7

11-15

9

17.6

16 or more

7

13.7

51

100.0

Total

Figure 15. Duration of prescription therapy experience in years
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Prescription Therapy Satisfaction
The ability to attend medical visits, feel as though your needs are met, and that
you have a part in selecting your own prescription therapy can have a positive influence
to HAART and regular medical visits that improve adherence.
Unhealthy behaviors, psychological concerns, incarceration, illness and financial
concerns had an impact on the satisfaction of our study participant’s satisfaction of
HAART. Table 5 exhibits that 37 study participants (72.5 %) were pleased with their
current prescription therapy, versus 14 (27.5%) who were not pleased with their current
prescription therapy.
Table 5
Satisfaction of prescription therapy
Are you pleased with your prescription therapy?
Yes
Valid No
Total

Frequency Percent
37
72.5
14

27.5

51

100.0

The ability to attend regular primary care visits allowed CD4 tests and viral load
tests laboratory work to be completed in a timely manner.
The results of these tests continue to have a direct impact on prescription therapy options.
Primary care visits were also used as a means to measure adherence as it relates to viral
load, CD4 count and HAART resistance. If any of the clients missed their scheduled
appointments the staff at each clinic would call them to reschedule. This was one of the
actions taken by each clinic to help improve their retention to care numbers and influence
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6-month primary care visits. In this study 88.2% (45) participants had attended 2 primary
care visits within the past 6 months (Table 6).
Table 6
Ability to attend 2 primary care visits within the past 6 months
Have you been able to attend 2 primary care visits within the
past 6 months?
Yes
Valid No
Total

Frequency Percent
45
88.2
6

11.8

51

100.0

Table 7 exhibits 70.6% (36) of study participants had previously been on a
HAART patient assistance program while waiting for their ADAP to be approved, while
29.4% (15) had never had to use patient assistance and where able to apply without any
issues. For individuals with financial limitations, the cost of HAART was a factor in
delaying HAART or having to stop taking HAART for an undisclosed time frame.
Table 7
AIDS Drug Assistance Program Experience
Have you ever been on Patient Assistance while pending
ADAP?
Yes
Valid No
Total

Frequency Percent
36
70.6
15
51

29.4
100.0
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Retention to Medical Care
Retention to medical care is essential to HAART compliance. Of the 51 study
participants, 49% (25) had at some point been out of medical care for more than 12
months and 51% (26) had not been out of medical care for more than 12 months (Table
8).
Table 8
Have you ever been out of medical care for more than 12 months?
Have you ever been out of medical care for more than 12
months?
Yes
Valid No
Total

Frequency Percent
25
49.0
26

51.0

51

100.0

HAART and Medical Care Noncompliance
Noncompliance to HAART occurs for a variety of reasons. The participants in
this study listed several of these. Figure 16 notes missed doctor visits was the primary
reason that 30 (24.4%) study participants identified as the reason they stopped taking
HAART. In addition, 17 (13.8%) said that cost was a factor, medication side effects 16
(13%), access to pharmacy 13 (10.6%), and lack of transportation 12 (9.8%) were
reported as the 5 most common reasons study participants stopped taking HAART.
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Figure 16. Reasons that caused study participants to stop taking HAART.

Examining Table 9, it shows responses from study participants noted that 94.1%
(48) of them had been in medical care on a regular basis for at least 12 months and that
5.9% (3) of participants that had not been in medical care on a regular basis.
Table 9. Has being in medical care on a regular basis (at least 12 months) helped with
HAART compliance?
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Table 9
Has being in medical care on a regular basis (at least 12 months) help with compliance
Has being in medical care on a regular basis (at least 12
months) help with compliance
Yes
Valid No
Total

Frequency Percent
48
94.1
3

5.9

51

100.0

Of the 25 individuals captured in Table 8, there were a variety of variables
selected on the survey as to why they had experienced being out of medical care for more
than 12 months (Table 10). Table 10 shows that financial concerns were the reason that
majority (22.8%) of study participants noted as the main reasons for their 12 or more
month medical care hiatus. This was trailed by lack of support system from family or
friends (17.5%) and tired of going to doctors’ appointments (15.8%).
Understanding the importance of medical care and that everyone has their own
self identifying circumstances of needing it, often times when someone drops out of
medical care, they usually reengage in medical care. Figure 17 displays that of the 25
study participants that had been out of medical care for more than 12 months, 16 study
participants shared that sickness was the most common factor that caused them to get
back into medical care and continue HAART, followed by the need for medication, as
noted by 11 study participants. Figure 17 displays that needing medication was the
second most documented response along with acquiring a new medical provider (7) and
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financial changes (4).

Figure 17. Reasons that study participants started to receive care again.
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Table 10.
What are the reasons that caused you to be out of medical care for more than 12 months?
Reasons that caused you to be out of medical care more than 12 months?
Frequency

Percent

Additional health challenges

7

12.3

Lack of transportation

7

12.3

Homelessness

3

5.3

10

17.5

9

15.8

13

22.8

Incarcerated (Jail or Prison)

7

12.3

Other

1

1.8

Total

57

100.0

Lack of support system from
family and friends
Valid Tired of going to doctor
appointments
Financial concerns

Results of Research Questions
Qualitative Research Questions
RQ1. What are the barriers causing African Americans living with HIV/AIDS to
have lower adherence rates with HAART than persons of other ethnic groups?
Although study participants had medical care appointments scheduled, there were
existing barriers that caused lapses in their medical care. Upon analyzing the data for this
study, the results showed study participants listed several barriers they have faced or are
currently dealing with, that impact their medical care and adherence to HAART. Of the
25 (49%) study participants that had been out of medical care for more than 12 months,
financial concerns were listed as the most common barrier (22.8%). Not having the
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support from family and friends was a barrier to study participants (17.5%), as well as
being tired of going to doctor appointments (15.8%).
Listed as the primary barrier for poor medical care and HAART adherence,
financial concerns are multifaceted. Nonstable income played a role in how a person is
able to navigate the actions needed for HAART compliance. Without a stable income,
proper housing is an issue, prescription purchases decrease, nutritional meals did not exist
due to the factor of cost, and basic self-care and hygiene needs can be problematic.
An additional barrier reported was a lack of support system from family and
friends impacted some (10) of our study participant. Without a proper support system,
some individuals living with HIV/AIDS find it (a) difficult to ask for help when and if
needed, (b) confide in others about their experiences, (c) be held accountable for their
actions and (d) trust others. Additional health challenges (12.3%), lack of transportation
(12.3%), and incarceration (12.3%) were also barriers in medical care that had a direct
influence on HAART noncompliance.
Additional health challenges presented other opportunities for additional stressors
such as taking more medication and having to attend more doctor visits for other health
issues. Lack of reliable transportation as a barrier, could come in many forms. Study
participants (12.3%) that did not have their own vehicle, relied on family or friends to get
to their medical appointments. Other means of transportation that were used to make
appointments were the buses or the trains within the public transportation system. If
someone who depended on public transportation cannot afford travel fare, they end up
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missing their medical care appointments if they are unable to be provided with alternate
means of transportation.
Three of the 51 study participants, who had been out of medical care for more
than 12 months, reported homelessness as a barrier to medical care. Homelessness, by
itself, is a very unfortunate situation to be in. However, being homeless and living with
HIV/AIDS presents challenges of safety, poor nutrition, noncompliance, financial strain
and often mental health concerns (Konkle-Parker, Erlen, & Dubbert, 2007).
Although study participants had medical care appointments scheduled, there are
existing barriers that have caused lapses in their medical care. Upon analyzing the data
for this study, the results showed study participants listed several barriers they have faced
or are currently dealing with, that impact their medical care and adherence to HAART.
Of the 25 (49%) study participants that had been out of medical care for more than 12
months, financial concerns were listed as the most common barrier (22.8%). Not having
the support from family and friends has been a barrier to study participants (17.5%), as
well as being tired of going to doctor appointments (15.8%).
Listed as the primary barrier for poor medical care and HAART adherence,
financial concerns are multifaceted. Nonstable income plays a role in how a person is
able to navigate the actions needed for HAART compliance. Without a stable income,
proper housing may be an issue, prescription purchases may decrease, nutritional meals
may not exist due to the factor of cost, and basic self-care and hygiene needs can be
problematic. Another barrier reported was a lack of support system from family and
friends impacted some (17.5%) of our study participants. Without a proper support
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system persons living with HIV/AIDS may find it (a) difficult to ask for help when and if
needed, (b) confide in others about their experiences, (c) be held accountable for their
actions, and (d) trust others. Additional health challenges (12.3%), lack of transportation
(12.3%), and incarceration (12.3%) were also barriers in medical care that had a direct
influence on HAART noncompliance.
Additional health challenges presented other opportunities for additional stressors
such as taking more medication and having to attend more doctor visits for other health
issues. Lack of reliable transportation as a barrier, could come in many forms. Study
participants (12.3%) that did not have their own vehicle, relied on family or friends to get
to their medical appointments. Other means of transportation that were used to make
appointments were the buses or the trains within the public transportation system. If
someone who depended on public transportation could not afford travel fare, they missed
some of their medical care appointments if they are unable to be provided with alternate
means of transportation.
RQ2. How can barriers for medical treatment of African Americans living with
HIV/AIDS be eliminated?
Of the 51 study participants, 32 (66.7 %) documented that lowering the cost of
HAART would eliminate their largest barrier or financial issues. Having pharmaceutical
companies to lower the cost of HAART medication would be beneficial to those persons
who are not on a patient assistance program, ADAP or have insurance to cover the cost.
As discussed in chapter 2, unfortunately, these medications are very costly and the
average cannot afford them. If a person cannot afford HAART, they will not be able to
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adhere to a prescription therapy regimen. More than 10% of study participants said that
access to medical clinics can be a barrier.
Depending on the location of local medical clinics, distance from their residence
may be a factor. Having access to an increased number of clinics would make it easier to
see doctors on a regular basis without having to wait so long for scheduled follow up
appointments. This would also possibly help with the transportation issue that 4.2% of
the 51 study participants said is a barrier to medical treatment. As noted in Figure 18,
9.4% of study participants said that having better medical care while incarcerated would
definitely alleviate a huge barrier in their care while they are incarcerated.
In addition to having an increased number of medical clinics, study participants
would benefit from gas vouchers, public transportation tokens or prepaid transit cards.
Side effects can interfere with medical treatment. Almost 2% of study participants
reputed that side effects of taking HAART interfere with their medical care. Side effects
varied from person to person, yet some of the most common side effects are diarrhea,
fatigue, nausea, and vomiting.
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Figure 18. How can barriers for medical treatment of HIV/AIDS be eliminated?
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Table 11
How can barriers for medical treatment of HIV/AIDS be eliminated?
Frequency
Lower the cost

Percent
32

26.0

Have more clinic available

5

4.1

Offer transportation

2

1.6

Help the homeless

2

1.6

Help with unemployment

2

1.6

Offer education on

2

1.6

Assist with getting food

1

.8

Better Medicines-less side

2

1.6

Total

48

39.0

System

75

61.0

123

100.0

assistance

Valid

medicines

effects

Missing
Total

Quantitative Research Questions
RQ3. Will attending two primary care visits within six months of being linked to
care increase the rate of compliance for African Americans on HAART living with
HIV/AIDS?
H01: Attending two primary care visits within six months of being linked to care
will not increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
HA1: Attending two primary care visits within six months of being linked to care
will increase the rate of compliance for African Americans on HAART living
with HIV/AIDS.
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Table 12
Model Summary of medical care predictors.
Model Summary
Model

R

1
a.

.685

R Square

a

Adjusted R

Std. Error of the

Square

Estimate

.469

.458

.240

Predictors: (Constant), Has being in medical care on a regular
basis (at least 12 months) help with compliance.

Table 13
The analysis of variance (ANOVA). A two-way ANOVA.
a

ANOVA
Model

1

Sum of Squares

df

Mean Square

Regression

2.482

1

2.482

Residual

2.813

49

.057

Total

5.294

50

F

Sig.

43.235

.000

b

a. Dependent Variable: Have you been able to attend 2 primary care visits within the past 6
months?
b. Predictors: (Constant), Has being in medical care on a regular basis (at least 12 months) help
with compliance

Table 14
Correlation coefficient of dependent variable of primary care visits.
Coefficients
Model

a

Unstandardized Coefficients

Standardized

t

Sig.

Coefficients
B

1

Std. Error

(Constant)

.063

.035

Has being in medical care

.938

.143

Beta

.685

1.807

.077

6.575

.000

on a regular basis (at least
12 months) help with
compliance

a. Dependent Variable: Have you been able to attend 2 primary care visits within the past 6 months?
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The overall model of the linear regression analysis was significant, R2 =.469,
adjusted R2 = .458, F(1, 49) = 43.24, p < .001. Specifically, being in medical care on a
regular basis accounted for 46.9% of the total variance in attending primary care visits.
The outcome of this analysis confirms my hypotheses (HA1) that attending two primary
care visits within six months of being linked to care increased the rate of compliance for
African Americans on HAART living with HIV/AIDS.
Regarding Tables 8 and 11, there is a direct correlation between being able to
attend 2 primary care visits within the past 6 months and being in medical care on a
regular basis (at least 12 months) that improved compliance rates. Showing an increase in
compliance, 88.2% (45) study participants were able to attend 2 primary care visits
within the past 6 months. Survey results also showed 94.1% (48) study participants
reported that being in medical care on a regular basis (at least 12 months) helped improve
their compliance rate for HAART.
RQ4. Will African Americans living with HIV/AIDS who have been out of care
for 12 or more months have a low linkage to care rate?
H02: African Americans that have been out of care for 12 or more months while
living with HIV/AIDS will not have a low linkage to care rate.
Table 15
Model Summary of Predictor of medical care.
Model Summary
Model

R

.3
1

58
a

R

Adjusted

Square

R Square

.128

.110

Std. Error of the Estimate

.307
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a.

Predictors: (Constant), Have you ever been out of medical care for more
than 12 months?

Table 16
The analysis of variance (ANOVA). A two-way ANOVA.
a

Model

Sum of

ANOVA
Mean
F
Square

df

Sig.

Square
s
Regression

.679

1

Residual

4.615

49

Total

5.294

50

1

.679 7.206

.010

.094

a. Dependent Variable: Have you been able to attend 2 primary care visits within the past 6
months?
b.

Predictors: (Constant), Have you ever been out of medical care for more than 12 months?

b

80

Table 17
Correlation coefficient of dependent variable.
Coefficients
Model

Unstandardized

Stan

Coefficients

dardi

t

Sig.

zed
Coeff
icient
s
B

Std.

Beta

Error
(Constant)
Have you
1

1.001E-

.061

.000

1.000

.086

.358 2.684

.010

013
.231

ever been out
of medical
care for more
than 12
months?

The overall model of the linear regression analysis was significant, R2 =.469,
adjusted R2 = .458, F(1, 49) = 7.206, p < .001. Specifically, being in medical care on a
regular basis accounted for 46.9% of the total variance in attending primary care visits.
The outcome of this analysis confirms my hypotheses (HA1) that attending two primary
care visits within six months of being linked to care increased the rate of compliance for
African Americans on HAART living with HIV/AIDS.
Concerning Table 8, 49% (25) of study participants reported being out of care for
more than 12 months. If a person is not in care, they are not able to receive ongoing
HAART. This results in low linkage to rates. Taking a look at Table 9, survey results also
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showed 94.1% (48) study participants reported that being in medical care on a regular
basis (at least 12 months) helped improve their compliance rate for HAART.
Evidence of Trustworthiness
Research studies should always be able to show reliability, validity, and
trustworthiness. As a researcher, it was my responsibility to ensure that my research
findings where accurately reflecting study participants experiences and to leave out any
preconceived notions that I may have had. Schreier (2012) noted when it comes to
research, people should be able to unmistakably follow the analysis and conclusion of
study results without any confusion.
Summary
Descriptive analysis and linear regressions were used in order to analyze my study
findings. This chapter was to share the findings of my research study. Chapter 5 will
discuss my research findings and conclusion. I will also document my recommendations
and the positive social changes that can happen as a result of my findings.
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Chapter 5: Interpretation of Findings
Introduction
The purpose of this research study was to explore the potential findings that
would lead to positive social changes by allowing African Americans living with
HIV/AIDS to have an advanced quality of life and lead to positive change by being able
to improve their health. This presented opportunity for these individuals to gain
employment, sustain positive relationships, to improve financial stability, present for
follow up medical visits and to even volunteer with local public health agencies that are
centered on HIV/AIDS patients as consumers. As previously stated, a mixed methods
approach, primarily qualitative, was used for the nature of the research study. Due to the
content of the research questions and information that were collected, this approach was
most sufficient. This helped to prevent bias.
Concept of Positive Social Change
Stressful situations in life can help to tear down a person’s beliefs, health status,
faith and relationships with others. Increasing awareness and helping to provide a clear
understanding of what causes such stressors and barriers, gives facts that can produce a
clear avenue of what needs to happen in an effort to address them. HAART compliance
influences social change, social position, personal and professional relationships,
financial stability, and quality of life. Having the ability to identify, reduce or eliminate
barriers of HAART adherence is definitely a positive attribute.
As shared in Chapter 2, when a parent is infected with HIV/AIDS, the quality of
their health may have a direct impact on the dynamics of their family. These dynamics
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may result in an increased responsibility load for others, including children, in the home.
When a person is HAART compliant and living a better quality of life, there are fewer
instances that family members will have to take on additional care responsibilities.
Allowing better attendance at work and school can lead to less stress and increased
successes that can be shared within families and their communities.
Family connections are a huge part of the African American community.
Knowing that a lack of support from family and friends was identified as a barrier to
HAART compliance, processes to improve the dynamics of relationships with loves ones
is critical. This social change is multileveled. It is a positive social change within
marriages, parent to child relationships, caregiver relationships, sibling relationships,
friendships and social relationships. Having the capacity to be an asset and productive
citizen in their community has a ripple effect. When family, friends or coworkers see this
behavior that led to a positive economic impact, it may perhaps influence them to
encourage their loved ones to continue with these behaviors and work collectively to
ensure it becomes habitual.
As a result of this research project, results can directly impact positive social
change. Results can lead to positive social changes by allowing African Americans living
with HIV/AIDS to have an advanced quality of life and extended longevity leading to
positive behavior changes by being able to improve their health. Increasing selfaccountability and self-confidence that an individual has transfers to increased social
activity. This would, in turn, allow more opportunities for gainful employment,
sustaining positive relationships, improving financial stability, being present for follow
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up medical visits and volunteering with local public health agencies that are centered on
HIV/AIDS patients as consumers. This also reveals potential to have a positive social
change on community development. Individually and collectively these indicators impact
social change in a progressive manner and initiates progressive civic engagement and
civic dialogue.
Furthermore, in order to make a positive social change there should be an
understanding of what treatment barriers are and why they exist. Knowing specific
barriers will allow for the implementation of policies and procedures, or programs that
will have a direct impact on eliminating or reducing such barriers. For example, if
transportation is a barrier, prepaid public transportation vouchers can be distributed to
clients to ensure that the cost of transportation for their follow up visit is covered. If
education on HAART is needed, speakers can attend Self Help Group Meetings or give
informal education sessions in the local health centers while clients wait for their
appointments. Thinking out of the box about creative ways that impact positive social
change can lead to an increase in healthy behavior change and knowledge about things
that directly impact a person’s well-being.
Interpretation of the Findings
Ninety four percent of participants in this study reported being in medical care on
a regular basis (at least 12 months) helped with HAART compliance. When a client
adheres to HAART they have a higher chance of being healthier than someone who does
not adhere to HAART. Again, this plays a vital role in retention to care. If a client has a
high retention to care rate, their CD4 count and viral load counts are able to be
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monitored. This has a direct impact on their physicians having a greater understanding of
how effective their HAART regimen is and how their body is reacting to any side effects
that may be present. This will allow the assessment of prescription therapy options as
well as the impact of any contraindications. It is important for patients to feel as though
they have an active part in the decision made that impact their care. Regular medical care
visits also help to establish the physician-patient relationship. It is important for clients to
be educated on any unhealthy behaviors that are known so that they can work with their
physician to create an action plan and referrals to help them manage their HIV/AIDS
diagnosis, as well as other things that may have a negative impact on their health.
Eliminating common barriers such as prescription cost, transportation issues, the
time it takes for follow up appointments and unstable support from their loves ones will
have a substantial impact on the quality life of a person living with HIV/AIDS. Ensuring
that a client has the benefit of receiving their follow up appointments, prescription refills,
and referrals at their medical care appointments can reduce the need for interim visits that
can be prevented.
The linear regression outcome for RQ3 showed the overall model of the linear
regression analysis was significant, R2 =.469, adjusted R2 = .458, F(1, 49) = 43.24, p <
.001. Specifically, being in medical care on a regular basis accounted for 46.9% of the
total variance in attending primary care visits. The outcome of this analysis confirms my
hypotheses (HA1) that attending two primary care visits within six months of being linked
to care increased the rate of compliance for African Americans on HAART living with
HIV/AIDS. The linear regression outcome for RQ4 highlighted the overall model of the
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linear regression analysis was significant, R2 =.469, adjusted R2 = .458, F(1, 49) = 7.206,
p < .001. Specifically, being in medical care on a regular basis accounted for 46.9% of
the total variance in attending primary care visits. The outcome of this analysis confirms
my hypotheses (HA1) that attending two primary care visits within six months of being
linked to care increased the rate of compliance for African Americans on HAART living
with HIV/AIDS.
Limitations of the Study
The intention of trustworthiness is to authenticate the argument that the
researchers’ findings are worthy of interest being given (Elo et al., 2014). Analysis
strategies should aspire to support trustworthiness by reporting the process of content
analysis accurately (Schreier, 2012). There were no major limitations in completing my
research study. The only limitation presented was the ability to ensure that all honest and
accurate information was captured and that each survey was completely filled out by the
study participants in higher HAART rates. Creswell (2009) noted validity is whether one
can draw meaningful and useful inferences from scores on the instruments (Creswell,
2009). Frankfort-Nachmias and Nachmias (2008) shared validity wants to ensure that
what is being measured is actually the intended target of measurement. The concept of
validity for measurement deals with (a) content validity, (b) empirical validity, and (c)
construct validity. Content validity the attributes of concept are completely covered by
the measurement instrument (Frankfort-Nachmias & Nachmias, 2008).
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Recommendations
Having consistent and taking part of access to healthcare is a major role in
improving the quality of life for persons living with HIV/AIDS. The duration of medical
care must improve. Helping to ensure that clients are in medical care should be one of the
primary goals of every medical provider team. If a person is not in care, they cannot be
fully HAART adherent. HAART has been successful in prolonging life expectancy and
decreasing the viral load of HIV in the human body (Cahill & Valadez, 2013). Persons on
HAART must adhere to strict guidelines in order to reduce their viral load and increase
their CD4 cells. Finding the prescription therapy regimen that works for them and that
they are please with is crucial. Follow up medical care visits must be addressed.
Physicians and medical clinicians, such as Physician Assistants, Nurse
Practitioners, and Registered Nurses should always remind their clients of the importance
of attending follow up medical visits. Most follow up appointments are scheduled 3-6
months out. Reminder calls for follow up appointments can be helpful in improving the
attendance rate for medical visits since some clients may lose their appointment cards, or
forget their appointment date.
As noted in Chapter 1, financial support for ADAP has tapered over the past few
years resulting in a waitlist for program enrollment, formulary reductions for various
medications and reduced coverage for HAART (Horneffer & Yang, 2013). To further
complicate issues, ADAPs were being inundated by persons who needed financial
assistance, and there was a rapid increase of persons on the ADAP waiting list between
the months of January 2010 through May 2011 (Figure 3).
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Financial strains are major. Helping to ensure that case managers and ADAP
coordinators are staffed sufficiently to meet the issue of supply and demand is a must.
This will help to reduce the length of time that it takes to get an ADAP appointment
scheduled. Without an ADAP appointment a person cannot be approved for a PAP that
will cover the financial expense of their HAART.
Addressing the issue of transportation would be vital to reducing this barrier.
Providing transportation vouchers for public transportation will assist with this, so will
pre-paid Uber gift cards for those persons that do not live near a train station or bus stop.
Getting a person to schedule an appointment and keep that appointment are 2 of the key
components of HAART implementation and adherence.
Implementing satellite clinics will give more options to attend medical care
appointments. With more medical care clinics available, some of the satellite locations
may be closer to residence or shelter for some clients. This may also improve the time it
takes to see a physician and go through the steps of starting HAART. Satellite clinics can
be successful with implementing HAART, completing follow up visits, and counseling
(Okonkwo et al, 2014).
Retention in HIV care is an essential measure for achieving long-term survival
while living with HIV/AIDS (Thompson et al., 2012). When medical care is not a regular
component of HAART the chances of being noncompliant increase and the potential for
declining in health may occur as a result of prescription refills ending, ADAP lapses, lack
of financial coverage for HAART, laboratory monitoring for viral load and CD4 counts
are not completed, viral load increases and CD4 count decrease.
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Establishing different support groups for clients to attend alone, and then another
support groups to attend with their loved ones, could help reduce the lack of support from
their family and friends. It is one thing to talk about what others deal with, but it is totally
different to hear it from someone who is dealing with face to face.
Homelessness, reported by itself is a very unfortunate situation to be in. However,
being homeless and living with HIV/AIDS presents challenges of safety, poor nutrition,
noncompliance, financial strain and often mental health concerns (Konkle-Parker, Erlen,
& Dubbert, 2007). With an increase in the homeless population, mobile HIV testing units
could be used to do HIV testing at homeless shelters and local parks where many
homeless people gather. If someone tests positive for HIV, that person would receive an
appointment to see a physician. Again, satellite clinics would help to reduce the wait time
to receive a medical care appointment with a physician. The connection between these
two things could help to increase HAART adherence rates through linkage to care efforts.
Unsuccessful implementation of the aforementioned recommendations can leave
the immune system at risk for opportunistic infections due to noncompliance with
HAART. HAART has been shown to decrease morbidity and mortality rates and reduce
mental health issues in persons living with HIV/AIDS (Hartzell, Janke & Weintrob,
2008).
Implications
If a person is not pleased with his/her treatment regimen, that could interfere with
HAART adherence and their overall quality of life. Medical care is a critical component
to HAART compliance, suppressed viral loads and quality of life. Persons with a history
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of medical care have a much higher retention to care rate than those who have never been
in medical care (Marks, Gardner, Craw, & Crepaz, 2010). Persons living with HIV/AIDS
taking HAART and attending regular medical visits are more likely to have suppressed
viral loads than those who see their providers intermittently (Giordano et al., 2007). A
person on HAART may have to deal with some less than ideal challenges, such as
multiple medication regimens, strict intake schedules, nutrition restrictions and adverse
reactions (Weiss et al, 2003).
Patient satisfaction impacts adherence in medical care and HAART (Dang,
Westbrook, Black, Rodriguez-Barradas & Giordano, 2013). When patients are not
pleased with their HAART they are less likely to continue their prescribed treatment
regimen. This can lead to drug resistance, viral load increase and CD4 decrease. This
exposes the need to improve the overall care experience as an innovative method for
optimizing HIV outcomes that lead to improved adherence (Dang, Westbrook, Black,
Rodriguez-Barradas & Giordano, 2013).
Incarcerated persons living with HIV/AIDS do not always know their HIV status
until, and if, they are tested while serving their sentenced time (Iroh, Mayo, & Nijhawan,
2015). If an incarcerated person knows that they are living with HIV/AIDS they having a
higher probability of being linked to care and stated on HAART (Iroh, Mayo, &
Nijhawan, 2015). African Americans are less than likely to be aware of their HIV status,
start HAART and medical care, or have a low viral load count than other ethnic group
(Iroh, Mayo, & Nijhawan, 2015).
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In Georgia, HIV/AIDS diagnosis cases are legally required to be reported to the
HIV/AIDS Epidemiology Section (HAES) (Georgia Department of Public Health, n.d.).
The Georgia Department of Public Health (DPH) (n.d.) noted Georgia has a dual
reporting system that legally requires both health care providers and laboratories to report
cases of HIV/AIDS. This is supposed to be completed within 7 days of diagnosis. Cases
are reported using a case report form that is sent to the HIV/AIDS surveillance program
(DPH, n.d.). Gostin (2008) notes threats pertaining to disease and illness are inexorably
spread to neighboring countries, regions and even continents through travel and
environmental factors. By having laws and policies in place sets the standard for federal
and state government public health programs to follow in order to protect their citizens in
the respective areas. Ethical consideration and ethical awareness is definitely something
that I considered when creating the survey for this research project.
Irrespective of gender, persons living with HIV/AIDS experience physical and/or
emotional violence from people that they are in relationship with, implying that HIV
status disclosure can be a risky perilous experience with partner shame, abuse, illtreatment, and financial abandonment (Colombini, James, & Ndwiga, 2016). These fears
can have a serious impact on medical care and increased HIV/AIDS rates
Kelly and Kalichman (2002) acknowledged HAART nonadherence destabilizes
the possibility of reduction in HIV transmission. HAART has been successful in
prolonging life expectancy and decreasing the viral load of HIV in the human body
(Cahill & Valadez, 2013). Persons on prescription therapy must adhere to strict
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guidelines in order to reduce their viral load and increase their CD4 cells. Finding the
prescription therapy regimen that works for them and that they are please with is crucial.
Burke et al. (2003) documents dissatisfaction with medical care has been shown
to impact treatment underutilization, discontinuity of care and poor clinical outcomes.
Patients have explicit desires and requests for services when they are in medical care
(Tateke, Woldie, & Ololo, 2012). As shared in Chapter 2, Stone et al. (2001) noted there
is a greater rate of self-reported adherence among persons whose HAART is less
complicated than other prescription therapy.
The more complex a person’s HAART is, the less likely they are to grasp details
of all of the components of HAART. The HIV Causal Collaboration (2011) documented
that persons who are compliant with their prescription regimen experience a higher rate
of healthy living and lower healthcare expenses during their lifetime since they are less
likely to access medical care than those persons who are less compliant with their
prescription regimen (Fleishman et al., 2010).
Creswell (2009) noted validity is whether one can draw meaningful and useful
inferences from scores on the instruments (Creswell, 2009). Frankfort-Nachmias and
Nachmias (2008) shared validity wants to ensure that what is being measured is actually
the intended target of measurement. The concept of validity for measurement deals with
(a) content validity, (b) empirical validity, and (c) construct validity. Content validity the
attributes of concept are completely covered by the measurement instrument (FrankfortNachmias & Nachmias, 2008).
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Conclusion
Dr. Chavez highlights that quantitative research looks at numbers, stats and rates
and looks at the where, when and what; however, qualitative asks with words how and
why and looks to tell the meaning of such (Laureate Education, Inc., 2008). There is a
gap in literature that focuses on the noncompliance of African Americans living with
HIV/AIDS who are on HAART. Although studies have been conducted on HAART, not
many have focused on the noncompliance and barriers of African Americans and
HAART alone.
Research studies should always be able to show reliability, validity, and
trustworthiness. The intention of trustworthiness is to authenticate the argument that the
researcher’s findings are worthy of interest being given (Elo et al., 2014). Analysis
strategies should aspire to support trustworthiness by reporting the process of content
analysis accurately (Schreier, 2012). HAART compliance data can be quantitative by
analyzing the quantity of clients that were compliant or noncompliant with HAART
during given time frames.
HAART compliance or noncompliance data can be also qualitative for the reason
that it allows individuals to express their beliefs, behaviors, and rational for actions. This
could provide additional clarity surrounding the results of the quantitative data.
HIV/AIDS infection can be very difficult in terms of coping with the diagnosis, and
medical care and HAART compliance may not be a priority to infected persons if other
pressing issues such as food, shelter, income, incarceration or behavioral health issues
exist.
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Appendix A: HIV/AIDS HAART Compliance and Primary Care Survey
Thank you for taking the time to answer the following questions. All of the
responses that you provide will be confidential. Your feedback will be analyzed and used
to improve primary care services, with a focus on prescription therapy. If you have any
questions about the survey, please contact Angela Corbin at 404-613-1267.
What is your

What is your

What is your

gender?

age?

marital Status?

What is your ethnicity?

o Male

o 22-29

o Single

o Black/or African

o Female

o 30-39

o Married

o Transgender

o 40-49

o Widowed

o White, Non-Hispanic

o 50-59

o Divorced

o Hispanic or Latino

o 60 +

o Separated

o Asian or Asian

American

American
o American Indian or
Alaskan Native
o Other

1. How long have you been in medical care for HIV?
o 1-2 Years
o 3-5 Years
o 6-10 Years
o 11-15 Years

107
o 16 or more years
2. How long have you been on prescription therapy for HIV?
o 1-2 Years
o 3-5 Years
o 6-10 Years
o 11-15 Years
o 16 or more years
3. Have you ever been out of medical care for HIV for more than 12 months?
o Yes
o No
4. If you answered Yes to #3, please select a reason below (Check all that apply):
o Other health challenges
o Lack of transportation
o Homelessness
o Lack of a support system from family or friends
o Tired of going to doctor’s appointments
o Financial concerns
o Incarcerated (Jail or Prison)
o Other, please specify reason: ____________________________________
5. If you answered Yes to #3, please select a reason below that you started to receive
care again:
o Sickness
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o Needed medicine
o New medical provider
o Financial changes (ex. loss of job or benefits)
o Other, please specify reason: ____________________________________
6. Has being in medical care on a regular basis (at least 12 months) helped you stay
compliant with your medications:
o Yes
o No
7. Have any of the options below caused you to stop taking your prescription
therapy for HIV? (Check all that apply):
o Missed doctors’ appointments
o Side effects of medication
o Cost of medication
o Inconvenience of taking medication
o Lack of transportation to doctors’ appointments
o Homelessness
o Access to pharmacy
o Lack of belief of success of treatment
o Poor relationship with medical provider
o Other, please specify reason: ____________________________________
8. Have you been able to attend two (2) primary care visits with your physician
within the past six (6) months?
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o Yes
o No
9. Have you ever been on a patient assistance for medicine while pending ADAP
approval?
o Yes
o No
10. Do you feel that adherence to HIV prescription therapy is not always successful?
Why or why not?
__________________________________________________________________
__________________________________________________________________

11. Do you believe that there are barriers for medical treatment for HIV/AIDS? If so,
how can they be eliminated?
__________________________________________________________________
__________________________________________________________________

12. Are you pleased with your prescription therapy that you are taking at the
moment?
o Yes
o No
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